Form 4 for AXGN Axogen, Inc.
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0000805928-26-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-18 | 2026-03-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | F - Tax | $32.84 | -2,870 | 256.4K | -1% | -$94.3K |
| DM | 2026-03-18 | 2026-03-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +17.9K | 268.0K | +7% | $0 |
| D | 2026-03-18 | 2026-03-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | S - Sale+OE | $32.84 | -5,221 | 262.8K | -2% | -$171.5K |
| DM | 2026-03-18 | 2026-03-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +17.9K | 11.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | F | D | 2,870 | $32.84 | 256,427 | D | — | — | (F2) This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale. |
| 2 | Common | Common Stock | 2026-03-16 | M | A | 6,363 | $0.00 | 259,297 | D | — | — | (F1) This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026. |
| 3 | Common | Common Stock | 2026-03-16 | M | A | 11,575 | $0.00 | 268,002 | D | — | — | (F1) This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026. |
| 4 | Common | Common Stock | 2026-03-16 | S | D | 5,221 | $32.84 | 262,781 | D | — | — | (F2) This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale. |
| 5 | Derivative | Restricted Stock Units | 2026-03-16 | M | A | 6,363 | $0.00 | 6,363 | D | — · — to — | 6,363 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F4) All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting dates. |
| 6 | Derivative | Restricted Stock Units | 2026-03-16 | M | A | 11,575 | $0.00 | 11,575 | D | — · — to — | 11,575 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F5) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date. |